New grades of low-density polyethylene (LDPE) for medical device and pharmaceutical packaging applications have been introduced by Repsol, a global energy and chemicals company headquartered in Madrid. It made the announcement at Compamed, a medical manufacturing trade show co-located with Medica this week in Düsseldorf, Germany.
The new LDPE grades offer processors a variety of alternatives designed to meet their needs as regards both melt flow index (0.3 to 20 g/10 minutes) and density, said Repsol. These new grades allow processors to manufacture novel containers, parts and films using lamination, blown film extrusion and injection molding.
The extension of the materials portfolio was made possible through the addition of the company’s LDPE plant in Sines, Portugal, to its Repsol pharma family, joining Spanish units in Tarragona, where polypropylene, LDPE and high-density polyethylene are produced, and Puertollano, which makes ethylene-vinyl acetate copolymers.
